No earnings within 2 weeks of this transaction.
| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Dec 23, 2025 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Shares |
| Direct/Indirect | Direct |
| Filing Date | Dec 30, 2025 |
| Document Date | Dec 23, 2025 |
| Shares Purchased | 313,841 |
| Price per Share | $3.85 |
| Total Value | $1,208,287.85 |
| Shares Owned After | 1,811,749 |
| Derivative | No |
| Accession Number | 0001140361-25-046786 |
| Document | View SEC Filing |